Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

By P. Wen, D. R. MacDonald, D. Reardon, T. Cloughesy, A. Sorensen, E. Galanis, J. Degroot, Wolfgang Wick, M. Gilbert, A. Lassman and 9 more. Journal of Clinical Oncology, 2010

3,326 citations recorded by the source corpus.

Subfields: Genetics, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/49f4a44009bff29c91543e87037df747485bb5ea

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

In Radiology, Nuclear Medicine and Imaging

Citations in the corpus

A survey of MRI-based brain tumor segmentation methods (2014, background): “MRI is attracting more and more attentions for the brain tumor diagnosis in the clinical [4] .”
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. (2014, background): “In the coming revision of the WHO classification, molecular markers should be integrated to refine the current morphology-based classification of anaplastic gliomas.(2,3) Among anaplastic gliomas, there is high correlation between oligodendroglial morphology and the 1p/19q co-deletion.”
Artificial intelligence in Cancer Imaging: Clinical Challenges and Applications (2019, background): “116,117 Although many conventional or advanced imaging techniques have been investigated to distinguish true tumor from treatment-related changes, it remains challenging to spatially characterize heterogeneous tissues that often contain both viable tumor and treatment-related changes.”
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma (2020, methodology): “Tumor assessments were performed by the investigator using contrast-enhancedMRI at baseline, day 1 ofweeks 7 and 13, and every 8 weeks thereafter.(8) Follow-up for survival occurred every 3 months.”
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome (2014, background): “The Macdonald criteria in HGG illustrate this point, asmeasuring contrast-enhancing tumor only has been superseded by the Response Assessment in NeuroOncology criteria, which incorporate measures of nonenhancing tissue (with likely microscopic foci of infiltrative neoplastic cells) into response cri”
3D Slicer as an Image Computing Platform for the Quantitative Imaging Network (2012, methodology): “, using the McDonald [68] or RANO criteria [69]).”